Peptidomimetic regulation of growth hormone secretion

Endocrine Reviews

Volumn 18, Issue 5, 1997, Pages 621-645

  Smith, Roy G ^a   Van der Ploeg, Lex H T ^b   Howard, Andrew D ^b   Feighner, Scott D ^b   Cheng, Kang ^b   Hickey, Gerard J ^b   Wyvratt Jr , Matthew J ^b   Fisher, Mike H ^b   Nargund, Ravi P ^b   Patchett, Arthur A ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 3 METHYL N [2,3,4,5 TETRAHYDRO 2 OXO 1 [[2' (1H TETRAZOL 5 YL) 1,1' BIPHENYL 4 YL]METHYL] 1H 1 BENZAZEPIN 3 YL]BUTANAMIDE; BENZODIAZEPINE DERIVATIVE; G 7502; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; IBUTAMOREN; ISONIPECOTIC ACID; LACTAM DERIVATIVE; RELEASING FACTOR; SOMATOSTATIN; SPIROINDANE DERIVATIVE; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; DRUG RECEPTOR BINDING; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; REVIEW; SIGNAL TRANSDUCTION;

EID: 9844230970     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.18.5.0316     Document Type: Review

References (182)

1. Momany FA, Bowers CY, Reynolds GA, Hong A, Newlander K 1984 Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology 114: 1531-1536
2. Bowers CY, Momany FA, Reynolds GA, Hong A 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114:1537-1545
3. Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, Newlander K 1981 Design, synthesis and biological activity of peptides which release growth hormone, in vitro. Endocrinology 108:31-39
4. Bowers CY 1996 Xenobiotic growth hormone secretagogues: growth hormone releasing peptides. In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 9-28
5. Bowers CY 1993 GH-releasing peptides: structure and kinetics. J Pediatr Endocrinol 6:21-31
6. Deghenghi R 1996 Growth hormone releasing peptides. In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 85-102
7. Fairhall KM, Mynett A, Thomas GB, Robinson ICAF 1996 Central and peripheral effects of peptide and nonpeptide GH secretagogues of GH release in vivo. In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 219-236
8. Smith RG, Cheng K, Pong S-S, Leonard RJ, Cohen CJ, Arena JP, Hickey GJ, Chang CH, Jacks TM, Drisko JE, Robinson ICAF, Dickson SL, Leng G 1996 Mechanism of action of CHRP-6 and nonpeptidyl growth hormone secretagogues. In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 147-163
9. Korbonits M, Grossman A 1995 Growth hormone-releasing peptide and its analogues: novel stimuli to growth hormone release. Trends Endocrinol Metab 6:43-49
10. Bertherat J, Bluet-Pajot MT, Epelbaum J 1995 Neuroendocrine regulation of growth hormone. Eur J Endocrinol 132:12-24
11. Guillemin R 1986 Hypothalamic control of pituitary functions. The growth hormone releasing factor. In: The Sherrington Lectures XVIII. University Press, Liverpool
12. Conway S, McCann SM, Krulich L 1985 On the mechanism of growth hormone autofeedback regulation: possible role of somatostatin and growth hormone-releasing factor. Endocrinology 117: 2284-2292
13. Frohman LA, Downs TR, Chomczynski P 1992 Regulation of growth-hormone secretion. Front Neuroendocrinol 13:344-405
14. Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB 1982 Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218:585-587
15. Rivier J, Spiess J, Thorner MO, Vale W 1982 Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300:276-278
16. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong S-S, Chaung L-YP, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund RP, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LHT 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
17. Kubiak TM, Friedman AR, Moseley WM 1996 Synthetic analogues of growth hormone releasing factor (GHRF) with improved pharmaceutical properties. In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 31-52
18. Deghenghi R, Boutignon F, Luono M, Grilli R, Guidi M, Locatelli V 1995 Small peptides as potent releasers of growth hormone. J Pediatr Endocrinol Metab 8:311-313
19. 2 on GRF stimulated growth hormone release and intracellular cAMP accumulation in rat primary pituitary cell cultures. Endocrinology 124: 2791-2797
20. 2) stimulates growth hormone secretion by depolarization in rat pituitary cell cultures. Proceedings of the 73rd Annual Meeting of The Endocrine Society, Washington, DC, 1991 (Abstract 230)
21. 2) and other secretagogues in rat somatotrophs. Proceedings of the 74th Annual Meeting of The Endocrine Society, San Antonio, TX, 1992 (Abstract 255)
22. Leonard RJ, Chaung L-YP, Pong S-S 1991 Ionic conductances of identified rat somatotroph cells studies by perforated patch recording are modulated by growth hormone secretagogues. Biophys J 59:254a (Abstract)
23. 2-induced growth hormone release from rat primary pituitary cells. Endocrinology 129:3337-3342
24. Mau SE, Witt MR, Bjerrum OJ, Saermark T, Vilhardt H 1995 Growth hormone releasing hexapeptide (GHRP-6) activates the inositol (1, 4, 5)-trisphosphate/diacylglycerol pathway in rat anterior pituitary cells. J Recept Signal Transduction Res 15:311-323
25. Herrington J, Hille B 1994 Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotrophs by two mechanisms. Endocrinology 135:1100-1108
26. Bresson-Bepoldin L, Dufy-Barbe L 1994 GHRP-6 induces a biphasic calcium response in rat pituitary somatotrophs. Cell Calcium 15:247-258
27. 2 stimulates growth hormone release through distinct receptor sites. J Endocrinol 129:11-19
28. Chen C, Clarke IJ 1992 Ion channels in the regulation of growth hormone secretion from somatotrophs by somatostatin. Growth Regul 2:167-174
29. Smith RG, Cheng K, Schoen WR, Pong S-S, Hickey GJ, Jacks TM, Butler BS, Chan WW-S, Chaung L-YP, Judith F, Taylor AM, Wyvratt Jr MJ, Fisher MH 1993 A nonpeptidyl growth hormone secretagogue. Science 260:1640-1643
30. Neill JD, Frawley LS 1983 Detection of hormone release from individual cells in mixed populations using a reverse hemolytic plaque assay. Endocrinology 112:1135-1137
31. Schoen WR, Pisano JM, Wyvratt Jr MJ, Fisher MH, Prendergast K, Cheng K, Chan WW-S, Butler BS, Smith RG, Ball RG 1994 A novel 3-substituted benzazepinone growth hormone secretagogue (L-692, 429). J Med Chem 37:897-906
32. Schoen WR, Wyvratt Jr MJ, Smith RG 1993 Growth hormone secretagogues. Annu Rep Med Chem 28:177-186
33. Cheng K, Chan WW-S, Butler BS, Wei L, Schoen WR, Wyvratt Jr MJ, Fisher MH, Smith RG 1993 Stimulation of growth hormone release from rat pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue. Endocrinology 260:1640-1643
34. Cheng K, Chan WW-S, Butler BS, Wei L, Smith RG 1993 A novel non-peptidyl growth hormone secretagogue. Horm Res 40:109-115
35. Frawley LS, Boockfor FR, Hoeffler JP 1985 Identification by plaque assays of a pituitary cell type that secrets both growth hormone and prolactin. Endocrinology 116:734-737
36. Frawley LS, Boockfor FR 1991 Mammusomatotropes: presence and functions in normal and neoplastic pituitary tissue. Endocr Rev 12:337-355
37. DeVita RJ, Schoen WR, Doldouras GA, Fisher MH, Wyvratt Jr MJ, Cheng K, Chan WW-S, Butler BS, Smith RG 1995 Heterocyclic analogs of the benzolactam nucleus of the non-peptidic growth hormone secretagogue L-692,429. Bioorgan Med Chem Lett 5:1281-1286
38. Schoen WR, Ok D, DeVita RJ, Pisano JM, Hodges P, Cheng K, Chan WW-S, Butler BS, Smith RG, Wyvratt Jr MJ, Fisher MH 1994 Structure-activity relationships in the amino acid sidechain of L-692,429. Bioorgan Med Chem Lett 4:1117-1122
39. Ok D, Schoen WR, Hodges P, DeVita RJ, Brown JE, Chang K, Chan WW-S, Butler BS, Smith RG, Fisher MH, Wyvratt Jr MJ 1994 Structure activity relationships of the non-peptidyl growth hormone secretagogue L-692,429. Bioorgan Med Chem Lett 4:2709-2714
40. Chu L, Mrozik H, Fisher MH, Bown JE, Cheng K, Chan WW-S, Schoen WR, Wyvratt Jr MJ, Butler BS, Smith RG 1995 Aliphatic replacements of the biphenyl scaffold of the non-peptidyl growth hormone secretagogues L-692,429 and L-692,585. Bioorgan Med Chem Lett 5:2245-2250
41. DeVita RJ, Schoen WR, Ok D, Barash L, Brown JE, Fisher MH, Hodges P, Wyvratt Jr MJ, Cheng K, Chan WW-S, Butler BS, Smith RG 1994 Benzolactam growth hormone secretagogues: replacements for the 2′-tetrazole moiety of L-692,429. Bioorgan Med Chem Lett 4:1807-1812
42. DeVita RJ, Schoen WR, Fisher MH, Frontier AJ, Pisano JM, Wyvratt Jr MJ, Cheng K, Chan WW-S, Butler BS, Hickey GJ, Jacks TM, Smith RG 1994 Benzolactam growth hormone secretagogues: carboxamides as replacements for the 2′-tetrazole moiety of L-692,429. Bioorgan Med Chem Lett 4:2249-2254
43. Chang CH, Rickes EL, Marsilio F, McGuire L, Cosgrove S, Taylor J, Chen HY, Feighner SD, Clark JN, DeVita RJ, Schoen WR, Wyvratt Jr MJ, Fisher MH, Smith RG, Hickey GJ 1995 Activity of a novel non-peptidyl growth hormone secretagogue L-700,653 in swine. Endocrinology 136:1065-1071
44. Leung KH, Cohn DA, Miller RR, Doss GA, Stearns RA, Simpson RE, Feeney WP, Chui S-HL 1996 Pharmacokinetics and disposition of L-692,429, a novel nonpeptidyl growth hormone secretagogue in preclinical species. Drug Metab Dispos 24:753-760
45. Wyvratt Jr MJ 1996 Non-peptidyl growth hormone secretagogues. In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 103-117
46. DeVita RJ, Wyvratt Jr MJ 1996 Benzolactam growth hormone secretagogues. Drugs Future 21:273-281
47. Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RSL, Lotti VJ, Cerino DJ, Chen TB, Kling PJ, Kunkel KA, Springer JP, Hirshfield J 1988 Methods for drug discovery: development of potent, selective orally effective cholecystokinin antagonists. J Med Chem 31:2235-2246
48. Chambers MS, Baker R, Billington DC, Knight AK, Middlemiss DN, Wong EHF 1992 Spiropiperidines as high-affinity, selective σ ligands. J Med Chem 35:2033-2039
49. Evans BE, Leighton JL, Rittle KE, Gilbert KF, Lundell GF, Gould NP, Hobbs DW, DiPardo RM, Veber DF, Pettibone DJ, Clineschmidt BV, Anderson PS, Freidinger RM 1992 Orally active, nonpeptide oxytocin antagonists. J Med Chem 35:3919-3927
50. Patchett AA, Nargund RP, Tata JR, Chen M-H, Barakat KJ, Johnston DBR, Cheng K, Chan WW-S, Butler BS, Hickey GJ, Jacks TM, Scleim K, Pong S-S, Chaung L-YP, Chen HY, Frazier E, Leung KH, Chui S-HL, Smith RG 1995 The design and biological activities of L-163,191 (MK-0677): a potent orally active growth hormone secretagogue. Proc Natl Acad Sci USA 92:7001-7005
51. Chen M-H, Steiner MG, Patchett AA, Cheng K, Wei L, Chan WW-S, Butler BS, Jacks TM, Smith RG 1996 Analogs of the orally active growth hormone secretagogue L-162,752. Bioorgan Med Chem Lett 6:2163-2168
52. Leung KH, Miller RR, Cohn DA, Colletti A, McGowan E, Feeney WP, Nargund RP, Rosegay A, Wallace A, Pharmacokinetics and disposition of MK-0677, a novel growth hormone secretagogue. Proceedings of the 7th International Society for the Study of Xenobiotics, San Diego, CA, 1996, vol 10:277 (Abstract)
53. Jacks TM, Smith RG, Judith F, Schleim K, Frazier E, Chen HY, Krupa DA, Hora Jr DH, Nargund RP, Patchett AA, Mickey GJ 1996 MK-0677, a potent, novel orally-active growth hormone (GH) secretagogue: GH, IGF-1 and other hormonal responses in beagles. Endocrinology 137:5284-5289
54. Hickey GJ, Jacks TM, Schleim K, Frazier E, Chen HY, Krupa DA, Feeney WP, Nargund RP, Patchett AA, Smith RG 1997 Repeat administration of the growth hormone secretagogue MK-0677 increases and maintains elevated IGF-1 levels in beagles. J Endocrinol 152:183-192
55. Nargund RP, Barakat KJ, Cheng K, Chan WW-S, Butler BS, Smith RG, Patchett AA 1996 Synthesis and biological activities of camphor-based non-peptide growth hormone secretagogues. Bioorgan Med Chem Lett 6:1265-1270
56. Nargund RP, Chen M-H, Johnston DBR, Barakat KJ, Tata JR, Cheng K, Jacks TM, Chan WW-S, Wei L, Butler BS, Hickey GJ, Smith RG, Patchett AA 1996 Peptidomimetic growth hormone secretagogues: synthesis and biological activities of analogs varied at the indole nucleus of the prototypical spiropiperidine L-162,752. Bioorgan Med Chem Lett 6:1731-1736
57. McDowell RS, Elias KA, Stanley MS, Burdick DJ, Burnier JP, Chan KS, Fairbrother WJ, Hammonds RG, Ingle GS, Jacobsen NE, Mortensen DL, Rawson TE, Won WB, Clark RG, Somers TC 1995 Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation. Proc Natl Acad Sci USA 92: 11165-11169
58. Elias KA, Ingle GS, Burnier JP, Hammonds RG, McDowell RS, Rawson TE, Somers TC, Stanley MS, Cronin MJ 1995 In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 136:5694-5699
59. Smith RG, Pong S-S, Hickey GJ, Jacks TM, Cheng K, Leonard RJ, Cohen CJ, Arena JP, Chang CH, Drisko JE, Wyvratt Jr MJ, Fisher MH, Nargund RP, Patchett AA 1996 Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog Horm Res 51:261-286
60. Pong S-S, Chaung L-YP, Dean DC, Nargund RP, Patchett AA, Smith RG 1996 Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 10:57-61
61. Dean DC, Nargund RP, Pong S-S, Chaung L-YP, Griffin PR, Melillo DG, Ellsworth RL, Van der Ploeg LHT, Patchett AA, Smith RG 1996 Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor. J Med Chem 39: 1767-1770
62. Pomes A, Pong S-S, Schaeffer JM 1996 Solubilization and characterization of a growth hormone secretagogue receptor from porcine anterior pituitary membranes. Biochem Biophys Res Commun 225:939-945
63. Hreniuk DL, Howard AD, Rosenblum CI, Palyha OC, Diaz C, Cully DF, Paress PS, McKee KK, Dashkevicz M, Arena JP, Liu KK, Schaeffer JM, Nargund RP, Smith RG, Van der Ploeg LHT, Feighner SD 1996 Cytochemical identification and cloning of a G-protein coupled growth hormone secretagogue receptor. Proceedings of the 26th Annual Meeting of The Society for Neuroscience, Washington, DC, vol 22:1300 (Abstract)
64. Chaung L-YP, Pong S-S, Dean D, Schaeffer JM, Smith RG, Characterization of a G-protein-linked receptor for peptidyl and non-peptidyl growth hormone secretagogue in rat and porcine hypothalamic and pituitary membranes. Proceedings of the 78th Annual Meeting of The Endocrine Society, San Francisco, CA (Abstract P1-613)
65. Adams EF, Petersen B, Lei T, Buchfelder M, Fahlbusch R 1995 The growth hormone secretagogue, L-692,429, induces phosphatidyl-inositol hydrolysis and hormone secretion by human pituitary tumors. Biochem Biophys Res Commun 208:555-561
66. Adams ME, Olivera BM 1994 Neurotoxins: overview of an emerging research technology. Trends Neurosci 17:151-155
67. Olivera BM, Miljanich GP, Ramachandran J, Adams ME 1994 Calcium channel diversity and neurotransmitter release: the omega-conotoxins and the omega-agatoxins. Annu Rev Biochem 63: 823-867
68. Ertel EA, Warren VA, Adams ME, Griffin PR, Cohen CJ, Smith MM 1994 Type III omega-agatoxins: a family of probes for similar binding sites on L- and N-type calcium channels. Biochemistry 33:5098-5108
69. McGurk JF, Pong S-S, Chaung L-YP, Gall M, Butler BS, Arena JP 1993 Growth hormone secretagogues modulate potassium currents in rat somatotrophs. Proceedings of the 23rd Annual Meeting of The Society of Neuroscience, Washington, DC, vol 19:1559 (Abstract)
70. Pong S-S, Chaung L-YP, Leonard RJ, The involvement of ions in the activity of a novel growth hormone secretagogue L-692,429 in rat pituitary cell culture. Proceedings of the 75th Annual Meeting of The Endocrine Society, Las Vegas, NV, 1993 (Abstract 487)
71. Koch BD, Blalock JB, Schonbrunn A 1988 Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. I. An increase in potassium conductance is responsible for both the hyperpolarization and the decrease in intracellular free calcium produced by somatostatin. J Biol Chem 263:216-225
72. Blondel O, Bell GI, Seino S 1995 Inositol 1,4,5-trisphosphate receptors, secretory granules and secretion in endocrine and neuroendocrine cells. Trends Neurosci 18:157-161
73. +2-dependent manner. Trends Neurosci 18:177-183
74. Mayo KE, Godfrey PA, DeAlmeida V, Miller T 1996 Structure, function, and regulation of the pituitary receptor for growth hormone releasing hormone. In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 53-71
75. Labrie F, Gagne B, Lefevre G 1983 Growth hormone-releasing factor stimulates adenylate cyclase activity in the anterior pituitary gland. Life Sci 33:2229-2233
76. Tang W-J, Gilman AG 1991 Type specific regulation of adenylyl cyclase by G protein β γ subunits. Science 254:1500-1503
77. Barinaga M, Yamanoto F, Rivier C, Vale W, Evans R, Rosenfeld MG 1983 Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature 306:84-85
78. Nakamura M, Sakanaka C, Aoki Y, Ogasawara H, Tsuji T, Kodama H, Matsumoto T, Shimizu T, Noma M 1995 Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. J Biol Chem 270:30102-30110
79. Maggio R, Vogel Z, Wess J 1993 Reconstitution of functional muscarinic receptors by co-expression of amino- and carboxyl-terminal receptor fragments. FEBS Lett 319:195-200
80. Wu D, Chen C, Zhang J, Bowers CY, Clarke IJ 1996 The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3′,5′-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs. J Endocrinol 148:197-205
81. Robb S, Cheek TR, Hamman FL, Hall LM, Midgley JM, Evans PD 1994 Agonist-specific coupling of a cloned Drosophila octopamine/ tyramine receptor to multiple second messenger systems. EMBO J 13:1325-1330
82. Aqua MS, Rizzu P, Lindsay EA, Shaffer LG, Zackai EH, Overhauser J, Baldini A 1995 Duplication of 3q syndrome: molecular delineation of the critical region. Am J Med Genet 55:33-37
83. Brachmann W 1916 Ein Fall von symmetrischer Monodaktylie durch ulnadefekt mit symmetrischer Flughautbildung in den Ellenbeugen, sowie, anderen Abnormitaten (Zwerghaftigheit, Halsrippen, Behaarung). Jahresber Kinderkeilk 84:224-235
84. de Lange C 1933 Sur un type nouveau de degeneration (Typus Amstelodamensis). Arch Med Enf 36:713-718
85. Jackson L, Kline AD, Barr MA, Koch S 1993 de Lange Syndrome: a clinical review of 310 individuals. Am J Med Genet 47:940-946
86. Dickson SL 1996 Evidence for a central site and mechanism of action of growth hormone releasing peptide (GHRP-6). In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 237-251
87. Fairhall KM, Mynett A, Smith RG, Robinson ICAF 1995 Consistent GH responses to repeated injections of GH-releasing hexapeptide (GHRP-6) and the nonpeptide GH secretagogue, L-692,585. J Endocrinol 145:417-426
88. Dickson SL, Leng G, Dyball REJ, Smith RG 1995 Central actions of peptide and nonpeptide growth hormone secretagogues in the rat. Neuroendocrinology 61:36-43
89. Sirinathsinghji DJS, Chen HY, Hopkins R, Trumbauer M, Heavens R, Rigby M, Smith RG, Van der Ploeg LHT 1996 Induction of c-fos mRNA in the arcuate nucleus of normal and mutant growth hormone-deficient mice by a synthetic non-peptidyl hormone secretagogue. Neuroreport 6:1989-1992
90. Bailey A, Smith RG, Leng G 1996 Activation of hypothalamic arcuate neurons in the urethane-anesthetized rat following systemic injection of growth-hormone secretagogues. J Physiol (Lond) 495:115-116
91. Lin S-C, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, Rosenfeld MG 1993 Molecular-basis of the little mouse phenotype and implications for cell-type specific growth. Nature 364:208-213
92. Jansson JO, Downs TR, Beamer WG, Frohman LA 1986 Receptor associated resistance to growth hormone-releasing hormone in dwarf 'little' mice. Science 232:511-513
93. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE 1993 GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-232
94. Schaible R, Gowen JW 1961 A new dwarf mouse. Genetics 46:896
95. Li S, Crenshaw III EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528-533
96. Dickson SL, Leng G, Robinson ICAF 1993 Systemic administration of growth hormone-releasing peptide (GHRP-6) activates hypothalamic arcuate neurons. Neuroscience 53:303-306
97. Dickson SL, Luckman SD 1997 Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurones in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 138:771-777
98. Fletcher TP, Thomas GB, Clarke IJ 1996 Growth hormone-releasing hormone and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6. Dornest Anim Endocrinol 13:251-258
99. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, Razafindraibe H, Conte-Devolx B, Deghenghi R, Lenaerts V, Oliver C 1994 Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135:1073-1076
100. Locke W, Kirgis HD, Bowers CY, Abdoh AA 1995 Intracerebro-ventricular growth hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats. Life Sci 56:1347-1352
101. Wahlestedt C, Skagerberg G, Ekman R, Heilig M, Sundler F, Hakanson R 1987 Neuropeptide (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res 417:33-38
102. Alvers HE, Ottenweller JE, Liou SY, Lumpkin MD, Andersen ER 1990 Neuropeptide Y in the hypothalamus: effect of corticosteroid and single-unit activity. Am J Physiol 258:R376-R382
103. Doutrelant-Viltart O, Dickson SL, Dyball REJ, Leng G 1995 Expression of Fos protein following growth hormone-releasing peptide (GHRP-6) injection in rat arcuate neurones retrogradely labelled by systemic flurogold administration. J Physiol 483:49-50
104. Bertherat J, Dournaud P, Berod A, Normand E, Bloch B, Rostene W, Kordon C, Epelbaum J 1992 Growth hormone-releasing hormone-synthesizing neurons are a subpopulation of somatostatin receptor-labeled cells in the rat arcuate nucleus - a combined in situ hybridization and receptor light-microscopic autoradiographic study. Neuroendocrinology 56:25-31
105. Guan X-M, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJS, Smith RG, Van der Ploeg LHT, Howard AD 1997 Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 48:23-29
106. Eichenbaum H, Otto T, Cohen NJ 1992 The hippocampus - what does it do? Behav Neural Biol 57:2-36
107. Pohorecki R, Domino EF 1987 Synaptic pharmacology of the hippocampus. Rev Clin Basic Pharmacol 6:189-211
108. Fallon JG, Loughlin SE 1995 Substantia nigra. In: Paxinos G (ed) The Rat Nervous System. Academic Press, New York, pp 215-237
109. Halliday G, Harding A, Paxinos G 1995 Serotonin and tachykinin systems. In: Paxinos G (ed) The Rat Nervous System. Academic Press, New York, pp 929-974
110. Mickey GJ, Jacks TM, Judith F, Taylor J, Clark JN, Smith RG 1994 In vivo efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue in beagles. Endocrinology 134:695-701
111. 4) levels in beagles. J Endocrinol 143:399-406
112. Zadik Z, Chalew SA, McCarter Jr RJ, Meistas M, Kowarski AA 1985 The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 60:513-516
113. Iranmanesh A, Lizzarralde G, Veldhuis JD 1991 Age and relative adiposity are specific determinants of the frequency and amplitude of GH secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081-1088
114. Corpas E, Harman SM, Blackman MR 1993 Human growth hormone and human aging. Endocr Rev 14:20-39
115. Rudman D 1985 Growth hormone, body composition, and aging. J Am Geriatr Soc 33:800-807
116. de Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA 1994 Serum lipid levels in growth hormone-deficient men. Metabolism 43:199-203
117. Salomon F, Cuneo RC, Hesp R, Sonksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803
118. Russell-Jones DL, Watts GF, Weissberger A, Naoumova R, Myers J, Thompson GR, Sonksen PH 1994 The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf) 41:345-350
119. Rosen T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
120. Fiasche R, Fideleff HL, Moisezowicz J, Frieder P, Pagano SM, Holland M 1995 Growth hormone neurosecretory disfunction in major depressive illness. Psychoneuroendocrinology 7:727-733
121. Sonntag WE, Forman LJ, Miki N, Trapp JM, Gottschall PF, Meites J 1982 L-dopa restores amplitude of growth hormone pulses in old male rats to that observed in young male rats. Neuroendocrinology 34:163-168
122. Wehrenberg WB, Ling N 1983 The absence of an age-related change in the pituitary response to growth hormone-releasing factor in rats. Neuroendocrinology 37:463-466
123. Welle S, Thornton C, Statt M, McHenry B 1996 Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J Clin Endocrinol Metab 81:3239-3243
124. Bowers CY 1994 Editorial: on a peptidomimetic growth hormone-releasing peptide. J Clin Endocrinol Metab 79:940-942
125. Laron Z 1995 Growth hormone secretagogues: clinical experience and therapeutic potential. Drugs 4:595-601
126. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal man and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 70:975-982
127. Hartman ML, Farello G, Pezzoli SS, Thorner MO 1992 Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men. J Clin Endocrinol Metab 74:1378-1384
128. Huhn WC, Hartman ML, Pezzoli SS, Thorner MO 1993 24-Hour growth hormone (GH)-releasing peptide (CHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP-6 bolus. J Clin Endocrinol Metab 76:1202-1208
129. Mericq V, Cassorla F, Garcia H, Avila A, Bowers CY, Merriam GR 1995 Growth-hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children. J Clin Endocrinol Metab 80:1681-1684
130. Arvat E, DiVito L, Gianotti L, Ramunni J, Boghen MF, Deghenghi R, Camanni F, Ghigo E 1997 Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. Metabolism 46:83-88
131. Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F 1994 Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. J Clin Endocrinol Metab 78:693-698
132. Imbimbo BP, Mant T, Edwards M, Amin D, Dalton N, Boutignon F, Lenaerts V, Wuthrich P, Deghenghi R 1994 Growth hormone-releasing activity of hexarelin in humans, a dose-response. Eur J Endocrinol 46:421-425
133. Gertz BJ, Barret JS, Eisenhandler R, Krupa DA, Wittreich JM, Seibold JR, Schneider SH 1993 Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab 77:1393-1397
134. Aloi JA, Gertz BJ, Hartman ML, Huhn WC, Pezzoli SS, Wittreich JM, Krupa DA, Thorner MO 1994 Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects. J Clin Endocrinol Metab 79:943-949
135. Gertz BJ, Sciberras DG, Yogendran L, Christie K, Bador K, Krupa DA, Wittreich JM, James I 1994 L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion. J Clin Endocrinol Metab 79:745-749
136. Kirk SE, Gertz BJ, Schneider SH, Hartman ML, Pezzoli SS, Wittreich JM, Krupa DA, Seibold JR, Thorner MO 1997 Effect of obesity and feeding on the growth hormone response to the GH secretagogue L-692,429 in young men. J Clin Endocrinol Metab 82:1154-1159
137. Chapman IM, Hartman ML, Pezzoli SS, Thorner MO 1996 Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults: a clinical research center study. J Clin Endocrinol Metab 81:2874-2880
138. Bach MA, Chapman IM, Farmer M, Schilling LM, Van Cauter E, Taylor AM, Bolognese J, Krupa DA, Gormley GJ, Thorner MO, An orally active growth hormone secretagogue (MK-0677) increases pulsatile, GH secretion and circulating IGF-1 in the healthy elderly. Proceedings of the 78th Annual Meeting of The Endocrine Society, San Francisco, CA, 1996 (Abstract OR15-2)
139. Chapman IM, Bach MA, Van Cauter E, Farmer M, Krupa DA, Taylor AM, Schilling LM, Cole KY, Skiles EH, Pezzoli SS, Hartman ML, Veldhuis JD, Gormley GJ, Thorner MO 1996 Stimulation of the growth hormone (GH)-insulin-like growth factor-1 axis by daily oral administration of a GH secretagogue (MK-0677) in healthy elderly subjects. J Clin Endocrinol Metab 81:4249-4257
140. Jansson JO, Eden S, Isaksson O 1985 Sexual dimorphism in the control of growth hormone secretion. Endocr Rev 6:128-150
141. Davis SL, Ohlson DL, Klindt J, Anfinson MS 1977 Episodic growth hormone secretory patterns in sheep: relationship to gonadal steroid hormones. Am J Physiol 233:E519
142. Steiner RA, Stewart JK, Barber J, Koerker D, Gooner CJ, Brown A, Illner P, Gale CC 1978 Somatostatin: a physiological role in the regulation of growth hormone secretion in the adolescent male baboon. Endocrinology 102:1587
143. Miller JD, Tannenbaum GS, Colle E, Guyda HJ 1982 Daytime pulsatile growth hormone secretion during childhood and adolescence. J Clin Endocrinol Metab 55:989
144. Chihara K, Minamitani N, Kaji H, Kodama H, Kita T, Fujita T 1983 Human pancreatic growth hormone-releasing factor stimulates release of growth hormone in conscious unrestrained male rabbits. Endocrinology 113:2081
145. Gevers EF, Wit JM, Robinson ICAF 1996 Growth, growth hormone (GH)-binding protein, and GH receptors are differentially regulated by peak and trough components of the GH secretory pattern in the rat. Endocrinology 137:1013-1018
146. Carlsson LMS, Jansson JO 1990 Endogenous growth hormone (GH) secretion in male rats is synchronized to pulsatile GH infusions given at 3-hour intervals. Endocrinology 126:6-10
147. Clark RG, Robinson ICAF 1985 Growth hormone (GH) responses to multiple injections of a fragment of human GH-releasing factor in conscious male and female rats. J Endocrinol 106:281-289
148. Tannenbaum GS, Martin JB 1976 Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology 98:562-570
149. Tannenbaum GS 1980 Evidence for autoregulation of growth hormone secretion via the central nervous system. Endocrinology 107: 2117-2120
150. Richman RA, Weiss JP, Hochberg Z, Florini JR 1981 Regulation of growth hormone release: evidence against feedback in rat pituitary cells. Endocrinology 108:2287-2292
151. Oliver C, Mical RS, Porter JC 1977 Hypothalamic-pituitary vasculature: evidence for retrograde blood flow in the pituitary stalk. Endocrinology 101:598-604
152. Bergland RM, Page RB 1978 Can the pituitary secrete directly to the brain? (affirmative anatomical evidence). Endocrinology 102: 1325-1338
153. Pelligrini E, Bluet-Pajot MT, Mounier F, Bennet P, Cordon C, Epelbaum J 1996 Central administration of growth hormone receptor mRNA antisense increases GH pulsatility and decreases hypothalamic somatostatin expression in rats. J Neurosci 16:8140-8148
154. Tannenbaum GS, Ling N 1984 The interrelationship of growth hormone (GH)-releasing factor and somatostatin in the generation of the ultradian rhythm of GH secretion. Endocrinology 115:1952-1957
155. Plotsky PM, Vale W 1985 Patterns of growth hormone-releasing factor and somatostatin into the hypophysial postal circulation of the rat. Science 230:461-463
156. Sato M, Chihara K, Kita T, Kashio Y, Okimura Y, Kitajima N, Fujita T 1989 Physiological role of somatostatin-mediated autofeedback regulation for growth hormone: importance of growth hormone in triggering somatostatin release during a trough period of pulsatile growth hormone release in conscious male rats. Neuroendocrinology 50:139-151
157. Kasting NW, Martin JB, Arnold MA 1981 Pulsatile somatostatin release from the median eminence of the unanaesthetized rat and its relationship to plasma growth hormone levels. Endocrinology 109:1739-1745
158. Robinson ICAF 1991 The growth hormone secretory pattern: a response to neuroendocrine signals. Acta Paediatr Scand [Suppl] 372:70-78
159. Wehrenberg WB, Brazeau P, Luhen R, Bohlen P, Guillemin R 1982 Inhibition of the pulsatile secretion by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology 111:2147-2148
160. Lumpkin MD, McDonald JK 1989 Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist. Endocrinology 124:1522-1531
161. Fletcher TP, Thomas GB, Willoughby JO, Clarke IJ 1994 Constitutive growth hormone secretion in sheep after hypothalamopituitary disconnection and the direct in viva pituitary effect of growth hormone releasing peptide 6. Neuroendocrinology 60:76-86
162. Vance ML, Kaiser DL, Evans WS, Furlanetto R, Vale W, Rivier J, Thorner MO 1985 Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-49): evidence for intermittent somatostatin secretion. J Clin Invest 75:1584-1590
163. Abe H, Molitch ME, van Wyk JJ, Underwood LE 1983 Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology 113:1319-1324
164. Clark RG, Carlsson LMS, Robinson ICAF 1988 Growth hormone (GH) secretion in the conscious rat: negative feedback of GH on its own release. J Endocrinol 119:201-209
165. Turner JP, Tannenbaum GS 1995 In vivo evidence of a positive role for somatostatin to optimize pulsatile growth hormone secretion. Am J Physiol (Endocrinol Metab) 269:E683-E690
166. Clark RG, Carlsson LMS, Rafferty B, Robinson ICAF 1988 The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release. J Endocrinol 119:397-404
167. Suzuki N, Okada K, Minami S, Wakabayashi I 1996 Inhibitory effect of neuropeptide Y on growth hormone secretion in rats is mediated by both Y1- and Y2-receptor subtypes and abolished after anterolateral deafferentation of the medial basal hypothalamus. Regul Pept 65:145-151
168. Cataldi M, Magnan E, Guillaume V, Dutour A, Conte-Devolx B, Lombardi G, Oliver C 1994 Relationship between hypophyseal portal GHRH and somatostatin and peripheral GH levels in the conscious sheep. J Endocrinol Invest 17:717-722
169. Frohman LA, Downs TR, Clarke IJ, Thomas GB 1990 Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. J Clin Invest 86:17-24
170. Drisko JE, Faidley TD, Hora Jr DH, Neibauer GW, Feeney WP, Friscino BF, Mickey GJ 1996 Transorbital approach to the porcine pituitary. J Invest Surg 9:305-311
171. Badger RM, Millard WJ, McCormick GF, Bowers CY, Martin JB 1984 The effects of growth hormone (GH) releasing peptides on GH secretion in perifused pituitary cells of adult male rats. Endocrinology 115:1432-1438
172. Hickey GJ, Drisko JE, Faidley TD, Chang CH, Anderson LL, Nicolich S, McGuire L, Rickes EL, Krupa DA, Feeney WP, Friscino BF, Cunningham P, Frazier E, Chen HY, Laroque P, Smith RG 1996 Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J Endocrinol 148:371-380
173. Pombo M, Barreiro J, Penalva A, Peino R, Dieguez C, Casaneuva FF 1995 Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. J Clin Endocrinol Metab 80: 3180-3184
174. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casaneuva FF 1995 Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection; evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80: 942-947
175. Conley LK, Teik J, Deghenghi R, Imbimbo BP, Giustina A, Locatelli V, Wehrenberg WB 1995 Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat. Neuroendocrinology 61:44-50
176. Stephens EA, Brown D, Leng G, Smith RG 1996 Computer simulation of a mathematical model of pituitary growth hormone release. J Physiol (Lond) 495:7P (Abstract)
177. Chihara K, Minamitani N, Kaji H, Arimura A, Fujita T 1981 Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood. Endocrinology 109: 2279-2281
178. Romancer ML, Reyl-Desmars F, Cherifi Y, Pigeon C, Bottari S, Meyer O, Lewin MJM 1994 The 86-kDa subunit of autoantigen Ku is a somatostatin receptor regulating protein phosphatase-2A activity. J Biol Chem 269:17464-17468
179. Florio T, Rim C, Hershberger RE, Loda M, Stork PJS 1994 The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol 8:1289-1297
180. Srikant CB, Shen S-H 1996 Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells. Endocrinology 137: 3461-3468
181. Buscail L, Delesque N, Esteve J-P, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bells GI, Leibow C, Schally AV, Vaysse N, Susini C 1994 Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 91:2315-2319
182. Huang X-Y, Morielli AD, Peralta EG 1993 Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor. Cell 75:1145-1156